These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32500979)

  • 41. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.
    Barletta JF; El-Ibiary SY; Davis LE; Nguyen B; Raney CR
    Mayo Clin Proc; 2013 Oct; 88(10):1085-90. PubMed ID: 24012413
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors of Clostridioides difficile Infection Among Asymptomatic, Colonized Patients: A Retrospective Cohort Study.
    Poirier D; Gervais P; Fuchs M; Roussy JF; Paquet-Bolduc B; Trottier S; Longtin J; Loo VG; Longtin Y
    Clin Infect Dis; 2020 May; 70(10):2103-2210. PubMed ID: 31290544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of Mortality in Cirrhosis Inpatients With Clostridium difficile Infection.
    Smith EZ; Northup PG; Argo CK
    J Clin Gastroenterol; 2018 Sep; 52(8):747-751. PubMed ID: 28644310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emerging alternatives against Clostridioides difficile infection.
    Romero-Rodríguez A; Martínez de la Peña C; Troncoso-Cotal S; Guzmán C; Sánchez S
    Anaerobe; 2022 Dec; 78():102638. PubMed ID: 36210608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Strategies to prevent adverse outcomes following
    Rauseo AM; Olsen MA; Reske KA; Dubberke ER
    Expert Rev Anti Infect Ther; 2020 Mar; 18(3):203-217. PubMed ID: 31976779
    [No Abstract]   [Full Text] [Related]  

  • 46. Evaluating
    Keats KR; Stitt TM; Chastain DB; Jivan BP; Matznick E; Waller JL; Clemmons AB
    J Oncol Pharm Pract; 2022 Apr; 28(3):542-550. PubMed ID: 33663290
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Interpretation of group standard for
    Wu Y; Lu JX; Yan ZZ; Liu YX; Gu WP; Fu XQ; Xu YC; Wu AH; Huang HH; Zong ZY; Jin DZ; Zhao JH; Chen Y; Liu WP; Li WG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Jan; 42(1):64-67. PubMed ID: 33503698
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Suggestions for the prevention of Clostridioides difficile spread within outpatient hemodialysis facilities.
    D'Agata EMC; Apata IW; Booth S; Boyce JM; Deaver K; Gualandi N; Neu A; Nguyen D; Novosad S; Palevsky PM; Rodgers D;
    Kidney Int; 2021 May; 99(5):1045-1053. PubMed ID: 33667504
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clostridium Difficile Infection in the Nephrology Ward.
    Dudzicz S; Adamczak M; Więcek A
    Kidney Blood Press Res; 2017; 42(5):844-852. PubMed ID: 29161712
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clostridium difficile infection is associated with poor outcomes in end-stage renal disease.
    Pant C; Deshpande A; Anderson MP; Sferra TJ
    J Investig Med; 2012 Feb; 60(2):529-32. PubMed ID: 22222233
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients.
    Miller R; Morillas JA; Brizendine KD; Fraser TG
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896665
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhanced Clostridioides difficile Infection Prevention With a Pharmacy-Controlled Policy That Adds a 3-Strain Lactobacillus Probiotic Concomitantly to Antibiotic Therapy.
    Maziade PJ; Ship N; Sniffen JC; Goldstein EJC
    Clin Infect Dis; 2021 Oct; 73(8):1524-1527. PubMed ID: 33966076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population.
    Morrisette T; Van Matre AG; Miller MA; Mueller SW; Bajrovic V; Abidi MZ; Benamu E; Kaiser JN; Barber GR; Chase S; Tobin J; Fish DN; Gutman JA
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):2091-2097. PubMed ID: 31255741
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clostridium difficile Infection Following Spine Surgery: Incidence, Risk Factors, and Association With Preoperative Antibiotic Use.
    Bell J; Vatani J; Raad M; Labaran L; Puvanesarajah V; Hassanzadeh H
    Spine (Phila Pa 1976); 2020 Nov; 45(22):1572-1579. PubMed ID: 32756273
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acid Suppression Medications During Hospitalization as a Risk Factor for Recurrence of Clostridioides difficile Infection: Systematic Review and Meta-analysis.
    Mehta P; Nahass RG; Brunetti L
    Clin Infect Dis; 2021 Jul; 73(1):e62-e68. PubMed ID: 32386313
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prescribed probiotic usage to prevent Clostridioides difficile infection among older patients receiving antibiotics: A retrospective cohort study.
    Mori N; Katsumata T; Takahashi T
    J Infect Chemother; 2023 Sep; 29(9):833-837. PubMed ID: 37211085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic Rifaximin Use in Cirrhotic Patients Is Associated with Decreased Rate of C. difficile Infection.
    Feuerstadt P; Hong SJ; Brandt LJ
    Dig Dis Sci; 2020 Feb; 65(2):632-638. PubMed ID: 31440997
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Australasian Society for Infectious Diseases guidelines for the diagnosis and treatment of Clostridium difficile infection.
    Cheng AC; Ferguson JK; Richards MJ; Robson JM; Gilbert GL; McGregor A; Roberts S; Korman TM; Riley TV;
    Med J Aust; 2011 Apr; 194(7):353-8. PubMed ID: 21470086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Substantial reduction of healthcare facility-onset Clostridioides difficile infection (HO-CDI) rates after conversion of a hospital for exclusive treatment of COVID-19 patients.
    Ochoa-Hein E; Rajme-López S; Rodríguez-Aldama JC; Huertas-Jiménez MA; Chávez-Ríos AR; de Paz-García R; Haro-Osnaya A; González-Colín KK; González-González R; González-Lara MF; Ponce-de-León A; Galindo-Fraga A
    Am J Infect Control; 2021 Jul; 49(7):966-968. PubMed ID: 33352250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Role of Probiotics in the Prevention of
    Dudzicz-Gojowy S; Więcek A; Adamczak M
    Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.